Form D · Pharmaceuticals

Ocugen, Inc.

Malvern, PA · CIK 0001696601

Offering snapshot reported Nov 19, 2018 · SEC filing

Reported sold
$350K
Offering amount: $4M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 5, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 19, 2018Initial$350,400No comparison4SEC filing
Feb 15, 2018Initial$5,000,000No comparison2SEC filing
Jun 13, 2017Initial$7,500,000No comparison6SEC filing
Feb 7, 2017Initial$200,000No comparison3SEC filing
Feb 2, 2017Initial$6,000,000No comparison9SEC filing

Offering details

Securities
Equity, Debt, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-326109

Source: Form D, filed Nov 19, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ravi Achar Director
Martin Coyne Director
Susan Drexler Executive
Daniel Jorgensen Executive
Charles Kang Executive
Uday Kompella Director, Promoter
Holdings Kvm Promoter
Kvm Kvm Holdings, Llc Promoter
Frank Leo Director
Shankar Musunuri Director, Executive
Manish Potti Director
Mannish Potti Director
Halit Suha Taspolatoglu Director
John Zhang Director
Junge Zhang Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
5 Great Valley Parkway Suite 160
Malvern, PA, 19355